BEAT CKD-Logo-Final

BEAT-CKD Management Committee (Chief Investigators)

 

100JonathanCraig

Jonathan Craig (Chair)

Sydney School of Public Health, The University of Sydney, Sydney, Australia; Centre for Kidney Research, The Children’s Hospital at Westmead, Sydney, Australia

Professor Craig is a clinical epidemiologist in CKD. He is the Coordinating Editor of Cochrane Kidney and Transplant, is the operational leader of KHA-CARI, and is on the Scientific Committee of Australasian Kidney Trials Network (AKTN). He is a paediatric nephrologist, and has a broad range of research skills including epidemiology, health economics, diagnostic test evaluation, systematic reviews and qualitative methods. He is the Chair of the BEAT-CKD program.


DavidJohnson-original (1)

David Johnson (Deputy-Chair)

Queensland School of Medicine, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia; Translational Research Institute, Brisbane, Australia; Metro South and Ipswich Nephrology and Transplant Services (MINTS), Brisbane, Australia

Professor Johnson is an expert in clinical trials, peritoneal dialysis (PD) and CKD. As Deputy-Chair of the AKTN, he will help facilitate the design and conduct of clinical trials under the oversight of BEAT-CKD, and contribute to the applied cohort studies and epidemiological research using the platform provided by the ANZDATA registry. He will oversee PD research, policy, guidelines and implementation; and contribute to implementation given his leadership in KHA-CARI, ISPD, the Australasian Primary Care Collaborative and the Kidney Check Australia Taskforce (KCAT).


Jeremy-Chapman (1)

Jeremy Chapman

Department of Renal Medicine, Westmead Hospital, Sydney, Australia; Centre for Transplant and Renal Research, Westmead Hospital, Sydney, Australia

Professor Chapman is widely recognised as a key, global figure in transplantation, and has played a major role in defining policy and practice  internationally. He will take responsibility for the applied area of kidney transplantation in the BEAT-CKD program, across the three themes of identification, evaluation and implementation, and will also provide a major input into mentoring and career advice for early and mid-career researchers.


carmel-hawley-original (1)

Carmel Hawley

Queensland School of Medicine, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia; Translational Research Institute, Brisbane, Australia; Metro South and Ipswich Nephrology and Transplant Services (MINTS), Brisbane, Australia

A/Prof Hawley, through her leadership of the AKTN, has become an internationally recognised expert in the design and conduct of randomised trials in CKD. She has formal qualifications in biostatistics and specific content expertise and research track record in haemodialysis. Her primary role under this BEAT-CKD program of work will be to continue to oversee the design, conduct and  management of all AKTN-coordinated trials, including providing guidance and mentorship to early career researchers involved in the design and conduct of these trials.


Stephen McDonald

Central Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, Australia; Royal Adelaide Hospital, Adelaide, Australia

Professor Stephen McDonald is a nephrologist with expertise in the design and conduct of complex observational studies, particularly studies arising from large scale registries of patients with end-stage kidney disease. This has developed in his role as ANZDATA Executive Officer. In the Beat-CKD program, he will take responsibility for the observational studies, which are especially critical for the identification and implementation themes. The BEAT-CKD program will enable extended follow up of trials through ANZDATA, together with the development of risk prediction and variation in care studies. He will contribute to implementation via collaborations with policy makers (AIHW and Organ Donation and Transplantation Authority).

Back to Top